Tin Yan Alvin Liu, M.D.

Headshot of Tin Yan Alvin Liu
  • Founding Director, Wilmer Precision Ophthalmology Center of Excellence
  • Assistant Professor of Ophthalmology
Male

Languages: English, Cantonese, Mandarin

Expertise

Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Holes, Retinal Detachment, Retinal Disease, Retinal Surgery, Retinal Vascular Disease, Retinal Vein Occlusion ...read more

Research Interests

application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, implementation of FDA-approved AI tools in the clinical setting ...read more

Request an Appointment

Insurance Information

Main Phone

Outside of Maryland & Washington D.C.

Request Appointment

International Patients

Request Appointment

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-3518
600 N. Wolfe Street
Wilmer Eye Institute
Baltimore, MD 21287
The Johns Hopkins Hospital - Google Maps

Johns Hopkins Medicine - Green Spring Station

Appointment Phone: 410-583-2802
10753 Falls Road
Johns Hopkins Wilmer Eye Institute, Pavilion II
Lutherville, MD 21093
Johns Hopkins Medicine - Green Spring Station - Google Maps

Background

T. Y. Alvin Liu, M.D. is an assistant professor of ophthalmology and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins.

He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole.

Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy.

In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma.

...read more

Titles

  • Founding Director, Wilmer Precision Ophthalmology Center of Excellence
  • Assistant Professor of Ophthalmology

Departments / Divisions

Education

Degrees

  • MD; Columbia University College of Physicians and Surgeons (2012)

Residencies

  • Ophthalmology; Johns Hopkins University School of Medicine (2016)

Board Certifications

  • American Board of Ophthalmology (Ophthalmology) (2020)

Additional Training

  • Bachelor of Arts (dual major in biology and economics); Cornell University
  • Phillips Exeter Academy
  • Advanced Specialty Training Program, Johns Hopkins University School of Medicine / Vitreoretinal (2018)

Research & Publications

Videos & Media

Recent News Articles and Media Coverage

AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018

AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019

How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021

Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021

Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022

Time to go multicultural. Retina Today March 1, 2023 

How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023

AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023

Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023

ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023

ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes  May 5, 2023

Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023

AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023

As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023

 

Is this you? Edit Profile
back to top button